The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zoledronic Acid 4mg/5ml Concentrate for solution for infusion

4 mg/5ml Concentrate for solution for infusion

Noridem Enterprises LtdPA1122/016/001

Main Information

Trade NameZoledronic Acid 4mg/5ml Concentrate for solution for infusion
Active SubstancesZoledronic acid
Strength4 mg/5ml
Dosage FormConcentrate for solution for infusion
Licence HolderNoridem Enterprises Ltd
Licence NumberPA1122/016/001

Group Information

ATC CodeM05BA Bisphosphonates
M05BA08 zoledronic acid


Licence Issued22/02/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back